Form 4: Calix CFO Executes Pre-Planned Stock Option Exercise and Sale
Insider Transaction Report
Calix, Inc.'s Chief Financial Officer, Cory Sindelar, exercised stock options and simultaneously sold an equal number of common shares on July 23, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Cory Sindelar, Chief Financial Officer of Calix, Inc. (CALX), engaged in a series of transactions on July 23, 2025.
- Sindelar exercised stock options to acquire 10,000 shares of common stock at an exercise price of $5.05 per share.
- Concurrently, Sindelar sold 10,000 shares of common stock at a price of $56.00 per share.
- These transactions were conducted pursuant to a Rule 10b5-1 trading plan, which was adopted on February 7, 2025.
- Following these transactions, Sindelar's direct beneficial ownership of common stock decreased from 86,285 shares to 76,285 shares.
- Sindelar retains 255,000 stock options (right to buy) with an exercise price of $5.05, which were fully vested and exercisable on October 1, 2021, and expire on October 1, 2027.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction (option exercise and sale) executed under a pre-planned 10b5-1 program, which is generally considered neutral in terms of company-specific sentiment. It reflects personal financial planning rather than a direct signal about the company's immediate future performance.
Positives
- The significant difference between the option exercise price of $5.05 and the sale price of $56.00 indicates substantial appreciation in Calix's stock value, reflecting positively on the company's past performance.
- The transaction was executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled and transparent approach to insider trading, which can reduce concerns about opportunistic selling.
Negatives
- The net reduction in the Chief Financial Officer's direct beneficial ownership of common stock, from 86,285 shares to 76,285 shares, represents a decrease in direct equity holdings by a key executive.
Stakeholder Impact
- Shareholders: May note the reduction in direct beneficial ownership by a key executive, though the pre-planned nature of the transaction under a 10b5-1 plan typically mitigates negative interpretations.
Key Dates
| Date | Description |
|---|---|
| 10/01/2021 | Date when 100% of the shares subject to the stock option became fully vested and exercisable. |
| 02/07/2025 | Date when the Rule 10b5-1 trading plan was adopted. |
| 07/23/2025 | Date of the stock option exercise and subsequent sale of common stock. |
| 07/24/2025 | Date the Form 4 filing was signed. |
| 10/01/2027 | Expiration date of the stock option. |
Recommendation
holdThe Form 4 filing details a pre-scheduled insider transaction (option exercise and sale) by the CFO under a Rule 10b5-1 plan. This type of transaction is typically for personal financial planning and does not inherently signal a change in the company's fundamental outlook or warrant a strong investment recommendation based solely on this filing. Investors should consider broader company financials and market conditions for investment decisions.
Keywords
Calix, CALX, Insider Trading, Form 4, Stock Option, 10b5-1 Plan, CFO, Stock Sale, Equity Transaction, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.